Group B Streptococcus Monoclonal Antibodies
|Catalog No.||Clone No.||MAb Subtype||Size||Library Pack No.||100ug/clone|
|15601||HSB11-206.4||IgG1||100ug, 500ug||156101||All 6 clones|
Format: Protein G-purified antibody in PBS, pH 7.4
Group B Streptococci (GBS) are found in about 25% of all healthy adults and pregnant women in the intestine, vagina, and rectal area. Most women who are carriers of the bacteria do not show any symptoms; however, under certain circumstances, infection of both the mother and/or the newborn can develop. In newborns, if the GBS infection develops in the first week of life, it is termed early-onset disease. If the GBS infection develops from 1 week to 3 months of age, it is referred to as late-onset disease. On average, approximately 1,000 babies in the United States develop early-onset disease each year, with similar rates for late-onset disease.
Antigen: Pool of the following UV-inactivated Group B Streptococci: Type Ia (ATCC #12400), Type Ib (ATCC #12401), Type Ic (ATCC #27591), Type II (ATCC #12973), and Type III (ATCC #12403).
Host Species: Mouse
Specificity: These antibodies recognize Group B Streptococci. They do not cross-react with Streptococcus groups A, C through G, Staphylococcus aureus, Lactobacillus acidophilus, Peptococcus prevotii, or Chlamydia trachomatis.
These antibodies have been qualified for use in ELISA to detect Group B Streptococci. Endusers should determine optimal concentrations for their applications.
Dilute in PBS or medium that is identical to that used in the assay system.
STORAGE AND STABILITY
These antibodies are stable for at least one (1) year at -20o to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles.
For in vitro investigational use only. Not intended for use in therapeutic or diagnostic procedures.